Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,957
Closed -$222K 47
2024
Q1
$222K Sell
1,957
-29
-1% -$3.32K 0.16% 45
2023
Q4
$219K Buy
+1,986
New +$198K 0.17% 42
2023
Q3
Sell
-1,957
Closed -$213K 45
2023
Q2
$213K Sell
1,957
-221
-10% -$23.6K 0.18% 45
2023
Q1
$221K Sell
2,178
-145
-6% -$15.3K 0.18% 44
2022
Q4
$255K Sell
2,323
-27
-1% -$2.8K 0.23% 37
2022
Q3
$227K Sell
2,350
-134
-5% -$14.3K 0.23% 34
2022
Q2
$270K Sell
2,484
-715
-22% -$81.2K 0.26% 36
2022
Q1
$379K Sell
3,199
-519
-14% -$64.3K 0.3% 43
2021
Q4
$523K Buy
+3,718
New +$476K 0.42% 43

Other funds holding ABT

Echo45 Advisors's ABT Position: Q2 2024 in Review

Echo45 Advisors sold out of Abbott (ABT) in Q2 2024, closing a stake of 1,957 shares — an estimated $222K sold.

Echo45 Advisors first reported a position in ABT in Q4 2021 and held it in 9 quarters. The position peaked at $523K in Q4 2021. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Echo45 Advisors reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Echo45 Advisors sold 1,957 Abbott shares in Q2 2024, an estimated $222K.
  • Echo45 Advisors first reported a position in Abbott in Q4 2021 and held it in 9 quarters.
  • Echo45 Advisors's Abbott position peaked at $523K in Q4 2021.
  • 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Echo45 Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.